TrialMolecular genetics & genomic medicine2025

A Randomized, Double-Blind, 2-Treatment, 2-Period, Crossover Phase 1 Study to Compare the Pharmacokinetics, Safety and Tolerability of 60 IU/Kg of Abcertin and Cerezyme in Healthy Volunteers Following a Single Intravenous Administration.

Eungu Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.